Medications

EU regulator advises AstraZeneca's COVID drug be cleared

The European Union's drug regulator said Thursday it was recommending that an antibody medication developed by AstraZeneca be authorized to help some vulnerable people avoid getting sick with the coronavirus.

Oncology & Cancer

Scientists discover molecule that kills pancreatic cancer cells

A research team led by scientists at Roswell Park Comprehensive Cancer Center has discovered a molecule that inhibits the growth and metastasis of pancreatic cancer cells through the iron metabolism pathway. Their findings, ...

Oncology & Cancer

Solving the mystery of a stubborn, and common, cancer gene

One of the major successes of decades of cancer research has been the development of drugs that specifically inactivate oncogenes, genes that function abnormally, causing cells to behave erratically, become malignant and ...

Oncology & Cancer

Scientists target protein to lower risk of prostate cancer spread

Targeting a specific protein that is often overexpressed in prostate cancer can help prevent or delay the disease from spreading to other parts of the body, according to a study led by Cedars-Sinai Cancer investigators.

Oncology & Cancer

Pushing past pancreatic tumors' defenses

Our immune systems have the potential to find and destroy cancer cells. But cancer cells can be clever and develop tricks to evade the immune system. Cold Spring Harbor Laboratory Professor Douglas Fearon and his former ...

page 28 from 40